1[1]Cotch M F, Hillier S L, Gibbs R S. et al. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy[J]. Am J Obstet Gynecol, 1998,178(2):374 - 380.
2[2]Lisiak M, Klyszejko C, Pierzchalo T, et al. Vaginal candidiasis: frequency of occurrence and risk factors[ J ]. Ginekol Pol,2000,71(9) :964 - 970.
3[3]Linhares L M, Witkin S S, Miranda S D, et al. Differentiation between women with vulvovaginal ymptoms who are positive or negative for Candida species by culture[J]. Infect Dis Obstet Gynecol,2001,9(4) :221 - 225.
4[4]Lisiak M, Klyszejko C, Marcinkowski Z, et al. Yeast species identification in vulvovaginal candidiasis: susceptibility to nystatin[J]. Ginekol Pol ,2000,71(9) :959 - 963.
5[5]Sobel J D. Use of antifungal drugs in pregnancy: a focus on safety[ J ]. Drug Saf,2000,23 ( 1 ): 77 - 85.
6[6]Blaschke H R. Vertical transmission of Candida and its consequences[ J ]. Mycoses, 1998,41 (Suppl 2): 31 - 36.
7[7]Mendling W. Vulvovaginal mycoses[J]. Z Arztl Fortbild Qualitatssich, 1998,92(3): 175 - 179.
8[8]Barousse M M, Steele C, Dunlap K, et al. Growth inhibition of Candida albicans by human vaginal epithelial cells[J]. J Infect Dis, 2001,184( 11 ): 1489 - 1493.
9[9]Thomas A, Kaur S, Somville T, et al. Abnormal glucose screening test followed by normal glucose tolerance test and regnancy outcome[J]. Saudi Med J ,2002,23(7) :814 - 818.
10[10]Abitzsch S, Stepan H, Sack U, et al. Detection of cervical immunoglobulin A in normal pregnancy [J]. J Perinat Med,2001,29(1) :36 - 41.
